THERAPEUTIC CLASS
Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol
Chronic liver disease (CLD) is a major health burden worldwide. Liver cirrhosis, a form of CLD is the
fifth most common cause of death in the UK. Acute-on-chronic liver failure (ACLF) is the result of an acute insult
superimposed on patients with liver cirrhosis as a result of precipitating events such as infection or bleeding. ACLF
has a high associated mortality as a result of multi-organ failure. The only effective treatment for CLD is liver
transplantation, but the treatment is limited by shortage of donor organs. As a result, alternative treatments such as
cell therapies have been studied in patients with liver diseases. This study will systematically review the evidence on
clinical effectiveness of cell therapies in patients
No other version available